| Formycon AG. (11/16/17). "Press Release: Formycon Sets Course for the Future and Confirms Management Board Members until mid-2022". Munich. |
2017-11-16 |
| Goodwin Procter LLP. (11/16/17). "Press Release: Intellia Therapeutics Closes $150 Million Public Offering of Common Stock". |
2017-11-16 |
| High-Tech Gründerfonds Management GmbH. (11/16/17). "Press Release: EWE Invests in High-Tech Gründerfonds III". |
2017-11-16 |
| Molecular Health GmbH. (11/16/17). "Press Release: Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction". Cambridge, MA. |
2017-11-16 |
| Ablynx N.V.. (11/16/17). "Press Release: Ablynx Announces Results for the First Nine Months of 2017 and a Year-to-Date Business Update". Ghent. |
2017-11-16 |
| Biocartis Group N.V.. (11/16/17). "Press Release: Biocartis Q3 2017 Business Update". Mechelen. |
2017-11-16 |
| bio.logis Genetic Information Management GmbH. (11/16/17). "Press Release: Laboratory Group Laboratoires Réunis Capitalizes Genetic Information Management Software Suite for Complex Laboratory Reports". |
2017-11-16 |
| Curetis N.V.. (11/16/17). "Press Release: Curetis Publishes Business and Financial Update for the First Nine Months of 2017". Amsterdam & Holzgerlingen. |
2017-11-16 |
| Roche. (11/16/17). "Press Release: FDA Approves Roche’s Hemlibra (emicizumab-kxwh) for Haemophilia A with Inhibitors". Basel. |
2017-11-16 |
| Boehringer Ingelheim. (11/15/17). "Press Release: Key Sub-analyses of RE-DUAL PCI Showed Large Reductions in the Incidence of Bleeding Complications if Pradaxa (dabigatran etexilate) Dual Therapy Was Used Instead of Warfarin Triple Therapy". Ingelheim. |
2017-11-15 |
| Arvinas, LLC. (11/15/17). "Press Release: Arvinas Expands Strategic License Agreement with Genentech". New Haven, CT. |
2017-11-15 |
| Xeltis AG. (11/15/17). "Press Release: Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs". Zurich & Eindhoven. |
2017-11-15 |
| Arsanis, Inc.. (11/15/17). "Press Release: Arsanis Announces Pricing of Initial Public Offering". Waltham, MA & Vienna. |
2017-11-15 |
| High-Tech Gründerfonds Management GmbH. (11/14/17). "Press Release: Scipio Bioscience Announces Its Seed Funding". |
2017-11-14 |
| Boehringer Ingelheim. (11/14/17). "Press Release: Jardiance Reduced Risk of Cardiovascular Death in Adults with Type 2 Diabetes and Peripheral Artery Disease". Ingelheim & Indianapolis, IN. |
2017-11-14 |
| Boehringer Ingelheim. (11/14/17). "Press Release: New RE-VERSE AD Analyses Provide Additional Insights on Impact of Praxbind (idarucizumab) in Pradaxa (dabigatran etexilate) Patients with Gastrointestinal Bleeding or Needing Emergency Surgery". Ingelheim |
2017-11-14 |
| Loxo Oncology, Inc.. (11/14/17). "Press Release: Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195". Stamford, CT. |
2017-11-14 |
| Qiagen N.V.. (11/14/17). "Press Release: Qiagen’s GeneReader NGS System Delivers Accuracy and Ease of Use for Clinical Research in Oncology". Hilden & Germantown, MD. |
2017-11-14 |
| Definiens AG. (11/13/17). "Press Release: Definiens Strengthens Position as Global Service Provider in Biopharma. Jacques Corriveau Joining as General Manager North America". Munich. |
2017-11-13 |
| CRISPR Therapeutics AG. (11/13/17). "Press Release: CRISPR Therapeutics and Casebia Collaborate with CureVac on mRNA for Gene-Editing Programs". Zug, Cambridge, MA, Tübingen & Boston, MA. |
2017-11-13 |
| Boehringer Ingelheim. (11/13/17). "Press Release: Cyltezo, Adalimumab Biosimilar from Boehringer Ingelheim, Approved in Europe for the Treatment of Multiple Chronic Inflammatory Diseases". Ingelheim. |
2017-11-13 |
| CRISPR Therapeutics AG. (11/13/17). "Press Release: CRISPR Therapeutics Announces Appointment of Michael Tomsicek as Chief Financial Officer". Zug & Cambridge, MA. |
2017-11-13 |
| Merck KGaA. (11/13/17). "Press Release: Merck and International Diabetes Federation Partner to Help Address Global Type 2 Diabetes Epidemic [The information contained in this release is not appropriate for audiences in the USA and Canada]". Darmstadt. |
2017-11-13 |
| Merck KGaA. (11/13/17). "Press Release: Merck Introduces Stericup Quick Release System for Improved Cell Culture Filtration". Darmstadt. |
2017-11-13 |
| Merck KGaA. (11/13/17). "Press Release: Merck Receives FDA Approval for New Gonal-f Prefilled Pen [Not intended for U.S. and UK based media]". Darmstadt. |
2017-11-13 |
| Royal Philips. (11/13/17). "Press Release: German Armed Forces to Use Customized Philips Lumify Ultrasound for Its Emergency and Rescue Operations". Amsterdam. |
2017-11-13 |
| Qiagen N.V.. (11/13/17). "Press Release: Qiagen Celebrates Surpassing 2,000 Cumulative Placements of QIAsymphony". Hilden & Germantown, MD. |
2017-11-13 |
| EBD Group. (11/13/17). "Press Release: BIO-Europe 2017 Brings over 4,000 Biotech and Pharma Execs to Berlin and Breaks All Previous Partnering Records". Carlsbad, CA & Berlin. |
2017-11-13 |
| GNA Biosolutions GmbH. (11/13/17). "Press Release: GNA Biosolutions Reveals New Ultrafast PCR Platform at Medica". Düsseldorf. |
2017-11-13 |
| Affimed N.V.. (12/11/17). "Press Release: Affimed Presents Data from Phase 1b Combination Study of AFM13 with Pembrolizumab at ASH". Heidelberg. |
2017-11-12 |
| Boehringer Ingelheim. (11/10/17). "Press Release: Boehringer Ingelheim Presents New Data for Pradaxa and Its Specific Reversal Agent Praxbind at AHA Scientific Sessions 2017". Ingelheim. |
2017-11-10 |
| DiaSorin S.p.A.. (11/9/17). "Press Release: Growth in Revenues and Net Profit in Q3 2017". Saluggia. |
2017-11-09 |
| Vetter Pharma International GmbH. (11/9/17). "Press Release: Vetter Expands Its Footprint in Asia Pacific Region. Company Establishes Its Presence in South Korea". Songdo & Ravensburg. |
2017-11-09 |
| Valneva S.E.. (11/9/17). "Press Release: Valneva Reports Strong Operational Performance for the First Nine Months of 2017". Lyon. |
2017-11-09 |
| Neurimmune AG. (11/9/17). "Press Release: Neurimmune Announces Collaboration with Ono Pharmaceutical in Neurodegenerative Diseases Field". Schlieren. |
2017-11-09 |
| AvroBio, Inc.. (11/9/17). "Press Release: AvroBio, Inc. Appoints Ian Clark to Its Board of Directors". Cambridge, MA. |
2017-11-09 |
| InflaRx N.V.. (11/8/17). "Press Release: InflaRx Announces Pricing of Initial Public Offering". Jena. |
2017-11-08 |
| Boehringer Ingelheim. (11/8/17). "Press Release: Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases". Ingelheim & London. |
2017-11-08 |
| Definiens AG. (11/8/17). "Press Release: Definiens Broadens Immuno-Oncology Service Offer. Predictive Multi-biomarkers for Accelerated Immuno-oncological Progress". Washington, D.C.. |
2017-11-08 |
| Evotec AG. (11/8/17). "Press Release: Evotec AG Announces First Nine-month 2017 Results and Corporate Update". Hamburg. |
2017-11-08 |
| CRISPR Therapeutics AG. (11/8/17). "Press Release: CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business Update". Zug & Cambridge, MA. |
2017-11-08 |
| Endress+Hauser AG. (11/8/17). "Press Release: Endress+Hauser Acquires Blue Ocean Nova. Intelligent Inline Spectrometers Strengthen the Process Analytical Instrumentation Portfolio". |
2017-11-08 |
| G1 Therapeutics, Inc.. (11/8/17). "Press Release: G1 Therapeutics Makes Key Executive Appointments. Barclay Phillips Appointed Chief Financial Officer and Senior Vice President, Corporate Development". Research Triangle Park, NC. |
2017-11-08 |
| MorphoSys AG. (11/7/17). "Press Release: MorphoSys Announces Third Quarter 2017 Results". Planegg. |
2017-11-07 |
| Compugen Ltd.. (11/7/17). "Press Release: Compugen Reports Third Quarter 2017 Results". Holon. |
2017-11-07 |
| Valneva S.E.. (11/7/17). "Press Release: Valneva Signs $39.6 Million Ixiaro Supply Contract with US Government". Lyon. |
2017-11-07 |
| Nouscom AG. (11/6/17). "Press Release: NousCom Raises €42 Million Series B Financing". Basel. |
2017-11-06 |
| Boehringer Ingelheim. (11/6/17). "Press Release: Efficacy and Safety Maintained in Patients Who Switched from Humira to Biosimilar Cyltezo". Ingelheim. |
2017-11-06 |
| Compugen Ltd.. (11/6/17). "Press Release: Compugen to Initiate Manufacturing of COM902, Its Lead antiTIGIT Monoclonal Antibody". Holon. |
2017-11-06 |
| Eurofins Scientific. (11/6/17). "Press Release: Eurofins Successfully Prices EUR 400m New Hybrid Bond". |
2017-11-06 |
| Evotec AG. (11/6/17). "Press Release: Evotec Joins Forces with Academic Leaders to Accelerate Drug Discovery in Kidney Diseases and Build »NEPLEX«". Hamburg. |
2017-11-06 |
| Qiagen N.V.. (11/6/17). "Press Release: Qiagen Reports Results for Third Quarter and First Nine Months of 2017". Venlo. |
2017-11-06 |
| Glycotope GmbH. (11/3/17). "Press Release: Celonic Acquires Glycotope’s Biomanufacturing Facility". Basel. |
2017-11-03 |
| Boehringer Ingelheim. (11/2/17). "Press Release: Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases including Nonalcoholic Steatohepatitis (NASH)". Ingelheim & Cambridge, MA. |
2017-11-02 |
| Topas Therapeutics GmbH. (11/2/17). "Press Release: Topas Therapeutics Extends Its Series A to EUR 18 Million (USD 21 Million) with Boehringer Ingelheim Venture Fund". Hamburg. |
2017-11-02 |
| Bruker Corporation. (11/2/17). "Press Release: Bruker Reports Third Quarter 2017 Financial Results". Billerica, MA. |
2017-11-02 |
| Servier. (11/2/17). "Press Release: Servier Germany to Co-promote Novartis’ Blockbuster Entresto". |
2017-11-02 |
| Merck KGaA. (11/1/17). "Press Release: Merck and Samsung BioLogics to Extend Strategic Alliance". Darmstadt. |
2017-11-01 |
| Bruker Corporation. (11/1/17). "Press Release: Bruker Merger of Sweden Subsidiaries". Solna. |
2017-11-01 |
| Novartis AG. (10/30/17). "Press Release: Novartis to Present First of its Kind Evidence for Cosentyx on Potential to Maintain Mobility in Patients with AS and PsA". Basel. |
2017-10-30 |
| Novartis AG. (10/30/17). "Press Release: Novartis Announces the Planned Acquisition of Advanced Accelerator Applications to Strengthen Oncology Portfolio". Basel. |
2017-10-30 |
| CureVac AG. (10/30/17). "Press Release: CureVac Announces Groundbreaking of Industrial-Scale GMP Production Facility for RNA Therapeutics". Tübingen. |
2017-10-30 |
| MorphoSys AG. (10/30/17). "Press Release: Dr. Markus Enzelberger Appointed MorphoSys's Chief Scientific Officer". Planegg. |
2017-10-30 |
| Euronext N.V.. (10/30/17). "Press Release: Theranexus Takes Its First Steps on Euronext Growth". Paris. |
2017-10-30 |
| Boehringer Ingelheim. (10/30/17). "Press Release: Boehringer Ingelheim Expands Collaboration with Sarah Cannon Research Institute to Investigate Novel Immuno-oncology Combination Therapy". Ingelheim & Nashville, TN. |
2017-10-30 |
| Glycotope GmbH. (10/30/17). "Press Release: Daiichi Sankyo and Glycotope Announce Option Agreement for Antibody Drug Conjugate Strategic Collaboration and Licensing". Tokyo, Basking Ridge, NJ & Berlin. |
2017-10-30 |
| Kymera Therapeutics LLC. (10/30/17). "Press Release: Kymera Therapeutics Announces Series A to Advance Novel Therapeutic Modality and Develop Innovative Therapies". Cambridge, MA. |
2017-10-30 |
| Qiagen N.V.. (10/30/17). "Press Release: Qiagen Accelerates Adoption of Molecular Testing for Life Sciences and Molecular Diagnostics Companies with Launch of Custom Solutions Business". Beverly, MA. |
2017-10-30 |
| Novartis AG. (10/28/17). "Press Release: Novartis PARADIGMS Data Show Children and Adolescents with MS Had an 82% Lower Relapse Rate with Gilenya vs. Interferon beta-1a". Basel. |
2017-10-28 |
| Novartis AG. (10/27/17). "Press Release: Sandoz Proposed Biosimilar Pegfilgrastim Accepted by EMA for Regulatory Review". Holzkirchen. |
2017-10-27 |
| Clariant. (10/27/17). "Press Release: Clariant and Huntsman Jointly Decided to Abandon Planned Merger of Equals". Muttenz. |
2017-10-27 |
| CureVac AG. (10/27/17). "Press Release: CureVac Initiates Phase I Clinical Trial of RNAdjuvant Candidate as Intratumoral Therapy for Solid Tumors". Tübingen & Boston, MA. |
2017-10-27 |
| 4SC AG. (10/26/17). "Press Release: 4SC Provides Q3 and 9M 2017 Update". Planegg-Martinsried. |
2017-10-26 |
| Topas Therapeutics GmbH. (10/26/17). "Press Release: Topas Therapeutics Appoints Rupert Sandbrink, M.D., Ph.D., as Chief Development Officer and Chief Medical Officer". Hamburg. |
2017-10-26 |
| Akampion. (10/26/17). "Press Release: Akampion Hosts Expert Panel at BIO-Europe 2017, Co-authors Scientific Article in Human Gene Therapy". |
2017-10-26 |
| Evolva Holding S.A.. (10/26/17). "Press Release: Evolva Announces Final Terms of Proposed Capital Increase [Not for release in US, CA, JP or AU or any jurisdiction where unlawful]". |
2017-10-26 |
| Evotec AG. (10/26/17). "Press Release: Evotec and Tesaro Enter Strategic Partnership to Discover Novel Immuno-Oncology Agents". Hamburg. |
2017-10-26 |
| InSphero AG. (10/26/17). "Press Release: InSphero and Charles River Announce PDX Partnership". Schlieren. |
2017-10-26 |
| Novartis AG. (10/25/17). "Press Release: Novartis Confirms Leadership in Multiple Sclerosis (MS) with Scientific Advancements and New Data presented at ECTRIMS". Basel. |
2017-10-25 |
| BioMed X GmbH. (10/25/17). "Press Release: BioMed X Announces Biomedical Research Collaboration with Janssen". Heidelberg. |
2017-10-25 |
| Thermo Fisher Scientific Inc.. (10/25/17). "Press Release: Thermo Fisher Scientific Reports Third Quarter 2017 Results". Waltham, MA. |
2017-10-25 |
| Sygnis AG. (10/24/17). "Press Release: Sygnis AG Announces the Launch of the Universal Lateral Flow Assay Kit and Associated Patent Filing". Madrid & Heidelberg. |
2017-10-24 |
| Idorsia Ltd.. (10/24/17). "Press Release: Idorsia Announces Financial Results as of 30 September 2017". Allschwil. |
2017-10-24 |
| AiCuris Anti-infective Cures GmbH. (10/24/17). "Press Release: AiCuris AIC649 Showed Potential for Functional Cure in Woodchuck Model for Chronic Hepatitis B". Wuppertal. |
2017-10-24 |
| Novartis AG. (10/24/17). "Press Release: Novartis Delivered Growth on Top and Bottom Line in All Divisions in Q3". Basel. |
2017-10-24 |
| Eurofins Scientific. (10/24/17). "Press Release: With 33% CAGR Annual Value Creation since Its IPO 20 Years Ago (over 296 Times Appreciation) a Study Finds that Eurofins Ranks First in Value Creation of All Stocks ÖListed in Europe since October 24, 1997 |
2017-10-24 |
| Fluidigm Corporation. (10/24/17). "Press Release: Fluidigm Announces Agreement with the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data Analysis". South San Francisco, CA. |
2017-10-24 |
| Fluidigm Corporation. (10/24/17). "Press Release: Fluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in Tissues". South San Francisco, CA. |
2017-10-24 |
| Ionicon Analytik GmbH. (10/24/17). "Press Release: Ionicon Presents the New Charon Aerosol Inlet for PTR-TOFMS". Innsbruck. |
2017-10-24 |
| Merck KGaA. (10/24/17). "Press Release: Canadian Patent Office to Grant Merck's Patent Application for CRISPR Technology". Darmstadt. |
2017-10-24 |
| Qiagen N.V.. (10/24/17). "Press Release: Qiagen and ICMP Launch Next-generation DNA Testing Solutions for Identifying Missing Persons". The Hague. |
2017-10-24 |
| Ascenion GmbH. (10/23/17). "Press Release: Ascenion’s Portfolio Company SurgVision Acquired by Bracco Imaging. Making Cancer Surgery more Precise". Munich. |
2017-10-23 |
| Novartis AG. (10/23/17). "Press Release: Novartis Combination Adjuvant Therapy Tafinlar + Mekinist Receives FDA Breakthrough Therapy Designation for Stage III BRAF V600 mutation-positive melanoma patients". Basel. |
2017-10-23 |
| Curetis N.V.. (10/23/17). "Press Release: Curetis Initiates U.S. FDA Study for Unyvero Invasive Joint Infections Cartridge". Amsterdam & Holzgerlingen. |
2017-10-23 |
| CureVac AG. (10/23/17). "Press Release: Publication in npj Vaccines Demonstrates CureVac’s RNActive Vaccine Is Superior to Licensed Vaccines". Tübingen & Boston, MA. |
2017-10-23 |
| MorphoSys AG. (10/23/17). "Press Release: MorphoSys Receives FDA Breakthrough Therapy Designation for Its Antibody MOR208 in Relapsed/Refractory DLBCL". Planegg. |
2017-10-23 |
| ADC Therapeutics S.A.. (10/23/17). "Press Release: ADC Therapeutics Announces Closing of $200 Million Private Financing to Fund Two Lead Programs Through Registrational Trials". Lausanne. |
2017-10-23 |
| Thermo Fisher Scientific Inc.. (10/23/17). "Press Release: New Unrivalled Capabilities Take GC-MS to the Next Level of Performance. Enhancements to Thermo Scientific Orbitrap GC-MS Systems". Sunnyvale, CA. |
2017-10-23 |
| UCB S.A.. (10/20/17). "Press Release: UCB First Nine Months Interim Report 2017 – Strong 9 Months Performance Allows for Increase of 2017 Financial Outlook". Brussels. |
2017-10-20 |
| Aelix Therapeutics S.L.. (10/20/17). "Press Release: Aelix Therapeutics Appoints Dr. Thomas Hecht as Chairman of the Board of Directors". |
2017-10-20 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 43 44 45 ... 52 53 54 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
